István Láng

机构：National Institute of Oncology

发表论文 153 篇 · 总被引 19202 次 · h-index 44

代表论文

• Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer (2017 · New England Journal of Medicine · 被引 1428)
• Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial (2015 · The Lancet · 被引 1236)
• Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer (2018 · New England Journal of Medicine · 被引 694)
• Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence (2016 · Journal of Clinical Oncology · 被引 254)
• Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials (2022 · Journal of Clinical Oncology · 被引 168)
• Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT (2019 · Journal of Clinical Oncology · 被引 149)